On September 20-21, 2016 Allison Dudley, Executive Director and David Flynn, Counsel to the Board attended an inter-governmental working meeting at the Food and Drug Administration to discuss the oversight of drug compounding and the relationship between the activities of the FDA and the states. The meeting provided an opportunity to discuss each state’s regulatory framework, recent FDA guidance documents, changes to the FDA’s inspection procedures, and information sharing challenges and opportunities.
More Latest News
June 13, 2019
Click here for information on the new international export pharmacy permit allowing safe importation of FDA-approved prescription drugs, pending federal approval. Continue reading
June 12, 2019
The Annual Long Range Planning meeting has been scheduled for Friday, October 18, 2019. Please click here for more information. Continue reading